From major journals, first or last author from the Institute for Cancer Research
Chen Y, He L, Ianevski A, Ayuda-Durán P, Potdar S, Saarela J, Miettinen JJ, Kytölä S, Miettinen S, Manninen M, Heckman CA, Enserink JM, Wennerberg K, Aittokallio T(2023) Robust scoring of selective drug responses for patient-tailored therapy selection Nat Protoc(in press) DOI 10.1038/s41596-023-00903-x, PubMed 37996540
Al Outa A, Hicks S, Thambawita V, Andresen S, Enserink JM, Halvorsen P, Riegler MA, Knævelsrud H(2023) CELLULAR, A Cell Autophagy Imaging Dataset Sci Data, 10(1), 806 DOI 10.1038/s41597-023-02687-x, PubMed 37973836
García-Díaz N, Wei Q, Taskén K(2023) Small molecule inhibitors targeting regulatory T cells for cancer treatment Eur J Immunol, e2350448(in press) DOI 10.1002/eji.202350448, PubMed 37937687
Hindi N, Razak A, Rosembaum E, Jonczak E, Hamacher R, Rutkowski P, Bhadri VA, Skryd A, Brahmi M, Alshibany A, Jagodzinska-Mucha P, Bauer S, Connolly E, Gelderblom H, Boye K, Henon C, Bae S, Bogefors K, Vincenzi B, Martinez-Trufero J, Lopez-Martin JA, Redondo A, Valverde C, Blay JY, Moura DSet al.(2023) Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registry ESMO Open, 8(6), 102045(in press) DOI 10.1016/j.esmoop.2023.102045, PubMed 38016251
Børø S, Thoresen S, Boge Brant S, Helland Å(2023) Initial investigation of using Norwegian health data for the purpose of external comparator arms - an example for non-small cell lung cancer Acta Oncol, 62(12), 1642-1648 DOI 10.1080/0284186X.2023.2264484, PubMed 37801361
Chen Y, He L, Ianevski A, Ayuda-Durán P, Potdar S, Saarela J, Miettinen JJ, Kytölä S, Miettinen S, Manninen M, Heckman CA, Enserink JM, Wennerberg K, Aittokallio T(2023) Robust scoring of selective drug responses for patient-tailored therapy selection Nat Protoc(in press) DOI 10.1038/s41596-023-00903-x, PubMed 37996540